–
X4 Pharmaceuticals, Inc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0
FY24:
1.80
FY25:
29.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−85.1
FY22:
−87.6
FY23:
−108
FY24:
−36.4
FY25:
−86.9
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−102
FY24:
–
FY25:
−81.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.7
FY22:
−93.8
FY23:
−101
FY24:
−37.1
FY25:
−79.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.7
FY22:
−93.9
FY23:
−101
FY24:
−37.5
FY25:
−79.2
All amounts in millions USD